株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

世界の動物用ワクチン市場:2017〜2021年

Global Veterinary Vaccines Market 2017-2021

発行 TechNavio (Infiniti Research Ltd.) 商品コード 498815
出版日 ページ情報 英文 70 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.38円で換算しております。
Back to Top
世界の動物用ワクチン市場:2017〜2021年 Global Veterinary Vaccines Market 2017-2021
出版日: 2017年05月03日 ページ情報: 英文 70 Pages
概要

世界の動物用ワクチン市場は食品安全性に対する高まる懸念によって恩恵を受けるとみられています。世界の動物用ワクチン市場は、2017〜2021年にかけCAGR4.81%で拡大すると予測されています。

当レポートでは、世界の動物用ワクチン市場について調査し、技術別、地域別の動向、競合動向、主要ベンダーのプロファイルなどなどをまとめています。

第1章 エグゼクティブダッシュボード

第2章 当レポートの範囲

第3章 調査方法

第4章 イントロダクション

第5章 動物の主な疾患の概要

第6章 市況

  • 市場概要
  • ファイブフォース分析

第7章 技術別市場セグメンテーション

  • 弱毒生ワクチン
  • 不活化ワクチン
  • トキソイドワクチン
  • DNAワクチン
  • 組み換えベクターワクチン

第8章 地域別市場セグメンテーション

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第9章 意思決定枠組み

第10章 促進因子と課題

第11章 市場動向

第12章 ベンダー環境

  • 競合シナリオ

第13章 主要ベンダー分析

  • Elanco
  • Merck
  • Merial
  • Zoetis
  • その他の注目すべきベンダー

第14章 付録

図表
  • Exhibit 01: Overview of major animal diseases
  • Exhibit 02: Global veterinary vaccines market snapshot
  • Exhibit 03: Global veterinary vaccines market 2016-2021 ($ millions)
  • Exhibit 04: Opportunity analysis in global veterinary vaccines market
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Market segmentation by technology 2016
  • Exhibit 07: Veterinary live attenuated vaccines: Vendors and indications
  • Exhibit 08: Global veterinary live attenuated vaccines market 2016-2021 ($ millions)
  • Exhibit 09: Veterinary inactivated vaccines: Vendors and indications
  • Exhibit 10: Global veterinary inactivated vaccines market 2016-2021 ($ millions)
  • Exhibit 11: Examples: Veterinary toxoid vaccines with their indications and vendors
  • Exhibit 12: Global veterinary toxoid vaccines market 2016-2021 ($ millions)
  • Exhibit 13: Veterinary DNA vaccines
  • Exhibit 14: Global veterinary DNA vaccines market 2016-2021 ($ millions)
  • Exhibit 15: Veterinary recombinant vector vaccines
  • Exhibit 16: Global veterinary recombinant vector vaccines market 2016-2021 ($ millions)
  • Exhibit 17: Global veterinary vaccines market by geography 2016 and 2021
  • Exhibit 18: Global veterinary vaccines market revenue by geography 2016-2021 ($ millions)
  • Exhibit 19: Market scenario in Americas
  • Exhibit 20: Veterinary vaccines market in Americas 2016-2021 ($ millions)
  • Exhibit 21: Market scenario in EMEA
  • Exhibit 22: Veterinary vaccines market in EMEA 2016-2021 ($ millions)
  • Exhibit 23: Market scenario in APAC
  • Exhibit 24: Veterinary vaccines market in APAC 2016-2021 ($ millions)
  • Exhibit 25: Major requirements for CVB product approval
  • Exhibit 26: Impact of drivers and challenges
  • Exhibit 27: Key drivers and challenges for impact analysis
  • Exhibit 28: Recent strategic alliances in animal healthcare
  • Exhibit 29: Competitive structure analysis of global veterinary vaccines market 2016
  • Exhibit 30: Competitive factors of global veterinary vaccines market
  • Exhibit 31: Market penetration of lifestyle drug manufacturers worldwide 2016
  • Exhibit 32: Strategic success factors of companies in global veterinary vaccine market
  • Exhibit 33: Key news in veterinary vaccines market
  • Exhibit 34: Elanco: Key highlights
  • Exhibit 35: Elanco: Strength assessment
  • Exhibit 36: Elanco: Strategy assessment
  • Exhibit 37: Elanco: Opportunity assessment
  • Exhibit 38: Merck: Key highlights
  • Exhibit 39: Merck: Strength assessment
  • Exhibit 40: Merck: Strategy assessment
  • Exhibit 41: Merck: Opportunity assessment
  • Exhibit 42: Merial: Key highlights
  • Exhibit 43: Merial: Strength assessment
  • Exhibit 44: Merial: Strategy assessment
  • Exhibit 45: Merial: Opportunity assessment
  • Exhibit 46: Zoetis: Key highlights
  • Exhibit 47: Zoetis: Strength assessment
  • Exhibit 48: Zoetis: Strategy assessment
  • Exhibit 49: Allergan: Opportunity assessment
  • Exhibit 50: Other prominent vendors
目次
Product Code: IRTNTR13085

About Veterinary Vaccines

Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products like meat, milk, and other products is increasing, and the mortality rate associated with infection transmission from animals to humans through these products is alarming. These factors are driving the vendors to invest in R&D to improve and expand their product portfolios, thereby driving the market growth.

Technavio's analysts forecast the global veterinary vaccines market to grow at a CAGR of 4.81% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global veterinary vaccines market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Veterinary Vaccines Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Elanco
  • Merck
  • Merial
  • Zoetis

Other Prominent Vendors

  • Advaxis
  • AmpliPhi Biosciences
  • Aratana Therapeutics
  • ARKO Labs
  • Bayer
  • CanFel Therapeutics
  • Ceva Animal Health
  • Colorado Serum Company
  • Epitopix
  • Genus
  • Hygieia Biological Laboratories
  • ImmuCell
  • Nexvet
  • Nuovo Biologics
  • UBI
  • Valneva
  • Vetoquinol
  • Virbac

Market driver

  • Dependency on livestock products.
  • For a full, detailed list, view our report

Market challenge

  • Manufacturing and storage issues.
  • For a full, detailed list, view our report

Market trend

  • Robust R&D and improved product portfolio.
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Key market highlights

PART 05: An overview of major animal diseases

PART 06: Market landscape

  • Market overview
  • Five forces analysis

PART 07: Market segmentation by technology

  • Live attenuated vaccines
  • Inactivated/Killed vaccines
  • Toxoid vaccines
  • DNA vaccines
  • Recombinant vector vaccines

PART 08: Geographical segmentation

  • Veterinary vaccines market in Americas
  • Veterinary vaccines market in EMEA
  • Veterinary vaccines market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

PART 12: Vendor landscape

  • Competitive scenario

PART 13: Key vendor analysis

  • Elanco
  • Merck
  • Merial
  • Zoetis
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations
Back to Top